Trexam 500 mg/5 ml (IM/IV Injection)
5 ml ampoule: ৳ 80.00 (1 x 5: ৳ 400.00)
Medicine Details
| Category | Details |
|---|---|
| Generic | Tranexamic acid |
| Company | Healthcare pharmaceuticals ltd |
| Also available as |
Title and Categories
- Trexam Capsules
- Medicine
- Hemostatic
- Anti-fibrinolytic drug
- Pharmaceutical
Dimensions
- Capsule Size: Standard
- Package Size: 30 capsules per pack
Color Options
- White capsules
Functions
- Prophylaxis of hemoptysis
- Therapy of hemoptysis
- Digestive hemorrhage therapy
- Prophylaxis and antihemorrhagic therapy during surgeries
- Antihemorrhagic therapy in urology
- Prophylaxis and therapy of post-partum and puerperium hemorrhages
- Antihemorrhagic therapy in obstetrics
- Prophylaxis and antihemorrhagic therapy in otorhinolaryngology
- Antihemorrhagic therapy in stomatology
- Supportive therapy in oncology
Materials
- Tranexamic acid
- Gelatin (Capsule shell)
Technical Specifications
- Active Ingredient: Tranexamic Acid
- Antifibrinolytic Action: Strong
- Acute Toxicity: Extremely Low
- Chronic Toxicity: Almost Non-existent
- Route of Absorption: Oral
- Excretion: Mainly Renal
- Effect Onset: 15-30 minutes after administration
Design Elements
- Capsule Shell: Gelatin
- Capsule Packaging: Blister Packs
Usability Features
- Dosage Forms:
- Capsules
- Oral Solution
- Dosage Administration: Oral, Intravenous, Intramuscular
- Dosage Recommendations:
- Adults: 500-1000 mg 3 times daily
- Children: 5-10 mg per kg body weight for prophylaxis
Interaction
- Incompatible with:
- Penicillins
- Antagonizes:
- Thrombolytic drugs
- Potential Increased Thrombus Formation with:
- Estrogen-containing drugs
Contraindications
- Known individual hypersensitivity
- Thromboembolic disease
- Arterial and venous thrombosis
- Endocavitary hemorrhages
- Serious kidney failure
Side Effects
- Sense of fatigue
- Conjunctival irritation
- Nasal blockage
- Itching
- Skin reddening
- Exanthems
- Nausea
- Diarrhea
- Gastric pyrosis
- Rare cases of postural hypotension
Pregnancy & Lactation
- Pregnancy: Contraindicated
- Lactation: Passes into breast milk in minimal concentration, unlikely to have antifibrinolytic effect in infant
Precautions & Warnings
- Use in cases of hyperfibrinolysis
- Prophylactic treatment initiation before operation
- Prolonged therapy for hemorrhages
- Caution in hematuria to prevent clot formation in urinary tract
- Avoid in serious renal insufficiency
- Administer with caution in cardiopathic and hepatopathic subjects
Therapeutic Class
- Anti-fibrinolytic drugs
- Haemostatic drugs
Storage Conditions
Dry place at 15-30°C, away from light and out of children's reach